Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 21 entries
Sorted by: Best Match Show Resources per page
2-Hydroxypyridine-.

ACS medicinal chemistry letters

Haudecoeur R, Carotti M, Gouron A, Maresca M, Buitrago E, Hardré R, Bergantino E, Jamet H, Belle C, Réglier M, Bubacco L, Boumendjel A.
PMID: 28105275
ACS Med Chem Lett. 2016 Nov 17;8(1):55-60. doi: 10.1021/acsmedchemlett.6b00369. eCollection 2017 Jan 12.

With the aim to develop effective and selective human tyrosinase inhibitors, we investigated aurone derivatives whose B-ring was replaced by a non-oxidizable 2-hydroxypyridine-

Cite
Haudecoeur R, Carotti M, Gouron A, et al. 2-Hydroxypyridine-. ACS Med Chem Lett. 2016;8(1):55-60doi: 10.1021/acsmedchemlett.6b00369.
Haudecoeur, R., Carotti, M., Gouron, A., Maresca, M., Buitrago, E., Hardré, R., Bergantino, E., Jamet, H., Belle, C., Réglier, M., Bubacco, L., & Boumendjel, A. (2017). 2-Hydroxypyridine-. ACS medicinal chemistry letters, 8(1), 55-60. https://doi.org/10.1021/acsmedchemlett.6b00369
Haudecoeur, Romain, et al. "2-Hydroxypyridine-." ACS medicinal chemistry letters vol. 8,1 (2017): 55-60. doi: https://doi.org/10.1021/acsmedchemlett.6b00369
Haudecoeur R, Carotti M, Gouron A, Maresca M, Buitrago E, Hardré R, Bergantino E, Jamet H, Belle C, Réglier M, Bubacco L, Boumendjel A. 2-Hydroxypyridine-. ACS Med Chem Lett. 2016 Nov 17;8(1):55-60. doi: 10.1021/acsmedchemlett.6b00369. eCollection 2017 Jan 12. PMID: 28105275; PMCID: PMC5238473.
Copy Download .nbib Format: NLM
Publisher Correction: Sex-specific outcome disparities in very old patients admitted to intensive care medicine: a propensity matched analysis.

Scientific reports

Wernly B, Bruno RR, Kelm M, Boumendil A, Morandi A, Andersen FH, Artigas A, Finazzi S, Cecconi M, Christensen S, Faraldi L, Lichtenauer M, Muessig JM, Marsh B, Moreno R, Oeyen S, Öhman CA, Pinto BB, Soliman IW, Szczeklik W, Niederseer D, Valentin A, Watson X, Leaver S, Boulanger C, Walther S, Schefold JC, Joannidis M, Nalapko Y, Elhadi M, Fjølner J, Zafeiridis T, De Lange DW, Guidet B, Flaatten H, Jung C.
PMID: 34226660
Sci Rep. 2021 Jul 05;11(1):14184. doi: 10.1038/s41598-021-93448-6.

No abstract available.

Cite
Wernly B, Bruno RR, Kelm M, et al. Publisher Correction: Sex-specific outcome disparities in very old patients admitted to intensive care medicine: a propensity matched analysis. Sci Rep. 2021;11(1):14184doi: 10.1038/s41598-021-93448-6.
Wernly, B., Bruno, R. R., Kelm, M., Boumendil, A., Morandi, A., Andersen, F. H., Artigas, A., Finazzi, S., Cecconi, M., Christensen, S., Faraldi, L., Lichtenauer, M., Muessig, J. M., Marsh, B., Moreno, R., Oeyen, S., Öhman, C. A., Pinto, B. B., Soliman, I. W., Szczeklik, W., Niederseer, D., Valentin, A., Watson, X., Leaver, S., Boulanger, C., Walther, S., Schefold, J. C., Joannidis, M., Nalapko, Y., Elhadi, M., Fjølner, J., Zafeiridis, T., De Lange, D. W., Guidet, B., Flaatten, H., & Jung, C. (2021). Publisher Correction: Sex-specific outcome disparities in very old patients admitted to intensive care medicine: a propensity matched analysis. Scientific reports, 11(1), 14184. https://doi.org/10.1038/s41598-021-93448-6
Wernly, Bernhard, et al. "Publisher Correction: Sex-specific outcome disparities in very old patients admitted to intensive care medicine: a propensity matched analysis." Scientific reports vol. 11,1 (2021): 14184. doi: https://doi.org/10.1038/s41598-021-93448-6
Wernly B, Bruno RR, Kelm M, Boumendil A, Morandi A, Andersen FH, Artigas A, Finazzi S, Cecconi M, Christensen S, Faraldi L, Lichtenauer M, Muessig JM, Marsh B, Moreno R, Oeyen S, Öhman CA, Pinto BB, Soliman IW, Szczeklik W, Niederseer D, Valentin A, Watson X, Leaver S, Boulanger C, Walther S, Schefold JC, Joannidis M, Nalapko Y, Elhadi M, Fjølner J, Zafeiridis T, De Lange DW, Guidet B, Flaatten H, Jung C. Publisher Correction: Sex-specific outcome disparities in very old patients admitted to intensive care medicine: a propensity matched analysis. Sci Rep. 2021 Jul 05;11(1):14184. doi: 10.1038/s41598-021-93448-6. PMID: 34226660; PMCID: PMC8257605.
Copy Download .nbib Format: NLM
Nephroprotective effect of .

Journal of traditional and complementary medicine

Sekiou O, Boumendjel M, Taibi F, Tichati L, Boumendjel A, Messarah M.
PMID: 33511062
J Tradit Complement Med. 2020 Jan 08;11(1):53-61. doi: 10.1016/j.jtcme.2020.01.001. eCollection 2021 Jan.

BACKGROUND AND AIM: In the present study, we investigate the phytochemical composition and the nephroprotective effects as well as the antioxidant properties of EXPERIMENTAL PROCEDURE: Wistar rats were divided into four groups of seven rats each: Group I: Normal...

Cite
Sekiou O, Boumendjel M, Taibi F, et al. Nephroprotective effect of . J Tradit Complement Med. 2020;11(1):53-61doi: 10.1016/j.jtcme.2020.01.001.
Sekiou, O., Boumendjel, M., Taibi, F., Tichati, L., Boumendjel, A., & Messarah, M. (2021). Nephroprotective effect of . Journal of traditional and complementary medicine, 11(1), 53-61. https://doi.org/10.1016/j.jtcme.2020.01.001
Sekiou, Omar, et al. "Nephroprotective effect of ." Journal of traditional and complementary medicine vol. 11,1 (2021): 53-61. doi: https://doi.org/10.1016/j.jtcme.2020.01.001
Sekiou O, Boumendjel M, Taibi F, Tichati L, Boumendjel A, Messarah M. Nephroprotective effect of . J Tradit Complement Med. 2020 Jan 08;11(1):53-61. doi: 10.1016/j.jtcme.2020.01.001. eCollection 2021 Jan. PMID: 33511062; PMCID: PMC7817709.
Copy Download .nbib Format: NLM
Design and Asymmetric Synthesis of beta-Strand Peptidomimetics.

The Journal of organic chemistry

Boumendjel A, Roberts JC, Hu E, Pallai PV, Rebek J.
PMID: 11667349
J Org Chem. 1996 Jun 26;61(13):4434-4438. doi: 10.1021/jo9522771.

We describe the asymmetric synthesis of non-peptidic compounds that feature rigid backbone conformations and present various side-chain functions. The key step in the synthesis of these compounds is the C-acylation of an appropriate ketone with a suitably protected aspartic...

Cite
Boumendjel A, Roberts JC, Hu E, et al. Design and Asymmetric Synthesis of beta-Strand Peptidomimetics. J Org Chem. 1996;61(13):4434-4438doi: 10.1021/jo9522771.
Boumendjel, A., Roberts, J. C., Hu, E., Pallai, P. V., & Rebek, J. (1996). Design and Asymmetric Synthesis of beta-Strand Peptidomimetics. The Journal of organic chemistry, 61(13), 4434-4438. https://doi.org/10.1021/jo9522771
Boumendjel, Ahcene, et al. "Design and Asymmetric Synthesis of beta-Strand Peptidomimetics." The Journal of organic chemistry vol. 61,13 (1996): 4434-4438. doi: https://doi.org/10.1021/jo9522771
Boumendjel A, Roberts JC, Hu E, Pallai PV, Rebek J. Design and Asymmetric Synthesis of beta-Strand Peptidomimetics. J Org Chem. 1996 Jun 26;61(13):4434-4438. doi: 10.1021/jo9522771. PMID: 11667349.
Copy Download .nbib Format: NLM
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Fatobene G, Rocha V, St Martin A, Hamadani M, Robinson S, Bashey A, Boumendil A, Brunstein C, Castagna L, Dominietto A, Finel H, Chalandon Y, Kenzey C, Kharfan-Dabaja M, Labussière-Wallet H, Moraleda JM, Pastano R, Perales MA, El Ayoubi HR, Ruggeri A, Sureda A, Volt F, Yakoub-Agha I, Zhang MJ, Gluckman E, Montoto S, Eapen M.
PMID: 32031876
J Clin Oncol. 2020 May 10;38(14):1518-1526. doi: 10.1200/JCO.19.02408. Epub 2020 Feb 07.

PURPOSE: To compare the outcomes of patients with Hodgkin or non-Hodgkin lymphoma undergoing nonmyeloablative haploidentical or unrelated cord blood (UCB) hematopoietic cell transplantation.PATIENTS AND METHODS: We retrospectively studied 740 patients with Hodgkin lymphoma (n = 283, 38%) and non-Hodgkin...

Cite
Fatobene G, Rocha V, St Martin A, et al. Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR. J Clin Oncol. 2020;38(14):1518-1526doi: 10.1200/JCO.19.02408.
Fatobene, G., Rocha, V., St Martin, A., Hamadani, M., Robinson, S., Bashey, A., Boumendil, A., Brunstein, C., Castagna, L., Dominietto, A., Finel, H., Chalandon, Y., Kenzey, C., Kharfan-Dabaja, M., Labussière-Wallet, H., Moraleda, J. M., Pastano, R., Perales, M. A., El Ayoubi, H. R., Ruggeri, A., Sureda, A., Volt, F., Yakoub-Agha, I., Zhang, M. J., Gluckman, E., Montoto, S., & Eapen, M. (2020). Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 38(14), 1518-1526. https://doi.org/10.1200/JCO.19.02408
Fatobene, Giancarlo, et al. "Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 38,14 (2020): 1518-1526. doi: https://doi.org/10.1200/JCO.19.02408
Fatobene G, Rocha V, St Martin A, Hamadani M, Robinson S, Bashey A, Boumendil A, Brunstein C, Castagna L, Dominietto A, Finel H, Chalandon Y, Kenzey C, Kharfan-Dabaja M, Labussière-Wallet H, Moraleda JM, Pastano R, Perales MA, El Ayoubi HR, Ruggeri A, Sureda A, Volt F, Yakoub-Agha I, Zhang MJ, Gluckman E, Montoto S, Eapen M. Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR. J Clin Oncol. 2020 May 10;38(14):1518-1526. doi: 10.1200/JCO.19.02408. Epub 2020 Feb 07. PMID: 32031876; PMCID: PMC7213591.
Copy Download .nbib Format: NLM
Modulatory Role of Selenium and Vitamin E, Natural Antioxidants, against Bisphenol A-Induced Oxidative Stress in Wistar Albinos Rats.

Toxicological research

Amraoui W, Adjabi N, Bououza F, Boumendjel M, Taibi F, Boumendjel A, Abdennour C, Messarah M.
PMID: 30057697
Toxicol Res. 2018 Jul;34(3):231-239. doi: 10.5487/TR.2018.34.3.231. Epub 2018 Jul 15.

Bisphenol A, an everywhere chemical, is applied as a plasticizer in polycarbonate plastics, which often used in our everyday products and in epoxy resins as protective coatings and linings for food and beverage cans for decades. Human exposure to...

Cite
Amraoui W, Adjabi N, Bououza F, et al. Modulatory Role of Selenium and Vitamin E, Natural Antioxidants, against Bisphenol A-Induced Oxidative Stress in Wistar Albinos Rats. Toxicol Res. 2018;34(3):231-239doi: 10.5487/TR.2018.34.3.231.
Amraoui, W., Adjabi, N., Bououza, F., Boumendjel, M., Taibi, F., Boumendjel, A., Abdennour, C., & Messarah, M. (2018). Modulatory Role of Selenium and Vitamin E, Natural Antioxidants, against Bisphenol A-Induced Oxidative Stress in Wistar Albinos Rats. Toxicological research, 34(3), 231-239. https://doi.org/10.5487/TR.2018.34.3.231
Amraoui, Wahiba, et al. "Modulatory Role of Selenium and Vitamin E, Natural Antioxidants, against Bisphenol A-Induced Oxidative Stress in Wistar Albinos Rats." Toxicological research vol. 34,3 (2018): 231-239. doi: https://doi.org/10.5487/TR.2018.34.3.231
Amraoui W, Adjabi N, Bououza F, Boumendjel M, Taibi F, Boumendjel A, Abdennour C, Messarah M. Modulatory Role of Selenium and Vitamin E, Natural Antioxidants, against Bisphenol A-Induced Oxidative Stress in Wistar Albinos Rats. Toxicol Res. 2018 Jul;34(3):231-239. doi: 10.5487/TR.2018.34.3.231. Epub 2018 Jul 15. PMID: 30057697; PMCID: PMC6057295.
Copy Download .nbib Format: NLM
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†.

Annals of oncology : official journal of the European Society for Medical Oncology

Robinson SP, Boumendil A, Finel H, Schouten H, Ehninger G, Maertens J, Crawley C, Rambaldi A, Russell N, Anders W, Blaise D, Yakoub-Agha I, Ganser A, Castagna L, Volin L, Cahn JY, Montoto S, Dreger P.
PMID: 26961149
Ann Oncol. 2016 Jun 01;27(6):1088-1094. doi: 10.1093/annonc/mdw124.

BACKGROUND: Patients with follicular lymphoma (FL) relapsing after an autologous transplant (autoSCT) may be treated with a variety of therapies, including a reduced intensity allogeneic transplant (RICalloSCT). We conducted a retrospective analysis of a large cohort of patients undergoing...

Cite
Robinson SP, Boumendil A, Finel H, et al. Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†. Ann Oncol. 2016;27(6):1088-1094doi: 10.1093/annonc/mdw124.
Robinson, S. P., Boumendil, A., Finel, H., Schouten, H., Ehninger, G., Maertens, J., Crawley, C., Rambaldi, A., Russell, N., Anders, W., Blaise, D., Yakoub-Agha, I., Ganser, A., Castagna, L., Volin, L., Cahn, J. Y., Montoto, S., & Dreger, P. (2016). Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†. Annals of oncology : official journal of the European Society for Medical Oncology, 27(6), 1088-1094. https://doi.org/10.1093/annonc/mdw124
Robinson, S P, et al. "Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†." Annals of oncology : official journal of the European Society for Medical Oncology vol. 27,6 (2016): 1088-1094. doi: https://doi.org/10.1093/annonc/mdw124
Robinson SP, Boumendil A, Finel H, Schouten H, Ehninger G, Maertens J, Crawley C, Rambaldi A, Russell N, Anders W, Blaise D, Yakoub-Agha I, Ganser A, Castagna L, Volin L, Cahn JY, Montoto S, Dreger P. Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†. Ann Oncol. 2016 Jun 01;27(6):1088-1094. doi: 10.1093/annonc/mdw124. PMID: 26961149.
Copy Download .nbib Format: NLM
Relative Change in NT-proBNP Level: An Important Risk Predictor of Cardiovascular Congestion in Haemodialysis Patients.

Nephron extra

Pastural-Thaunat M, Ecochard R, Boumendjel N, Abdullah E, Cardozo C, Lenz A, M'pio I, Szelag JC, Fouque D, Walid A, Laville M.
PMID: 23341833
Nephron Extra. 2012 Jan;2(1):311-8. doi: 10.1159/000343897. Epub 2012 Dec 12.

BACKGROUND: Cross-sectional studies have shown that B-type natriuretic peptide (BNP) and its N-terminal fragment (NT-proBNP) are predictive of cardiovascular death in haemodialysis (HD) patients. In the present study, we tested the hypothesis that monitoring NT-proBNP measurements adds further prognostic...

Cite
Pastural-Thaunat M, Ecochard R, Boumendjel N, et al. Relative Change in NT-proBNP Level: An Important Risk Predictor of Cardiovascular Congestion in Haemodialysis Patients. Nephron Extra. 2012;2(1):311-8doi: 10.1159/000343897.
Pastural-Thaunat, M., Ecochard, R., Boumendjel, N., Abdullah, E., Cardozo, C., Lenz, A., M'pio, I., Szelag, J. C., Fouque, D., Walid, A., & Laville, M. (2012). Relative Change in NT-proBNP Level: An Important Risk Predictor of Cardiovascular Congestion in Haemodialysis Patients. Nephron extra, 2(1), 311-8. https://doi.org/10.1159/000343897
Pastural-Thaunat, M, et al. "Relative Change in NT-proBNP Level: An Important Risk Predictor of Cardiovascular Congestion in Haemodialysis Patients." Nephron extra vol. 2,1 (2012): 311-8. doi: https://doi.org/10.1159/000343897
Pastural-Thaunat M, Ecochard R, Boumendjel N, Abdullah E, Cardozo C, Lenz A, M'pio I, Szelag JC, Fouque D, Walid A, Laville M. Relative Change in NT-proBNP Level: An Important Risk Predictor of Cardiovascular Congestion in Haemodialysis Patients. Nephron Extra. 2012 Jan;2(1):311-8. doi: 10.1159/000343897. Epub 2012 Dec 12. PMID: 23341833; PMCID: PMC3551398.
Copy Download .nbib Format: NLM
Reliability of the Clinical Frailty Scale in very elderly ICU patients: a prospective European study.

Annals of intensive care

Flaatten H, Guidet B, Andersen FH, Artigas A, Cecconi M, Boumendil A, Elhadi M, Fjølner J, Joannidis M, Jung C, Leaver S, Marsh B, Moreno R, Oeyen S, Nalapko Y, Schefold JC, Szczeklik W, Walther S, Watson X, Zafeiridis T, de Lange DW.
PMID: 33534010
Ann Intensive Care. 2021 Feb 03;11(1):22. doi: 10.1186/s13613-021-00815-7.

PURPOSE: Frailty is a valuable predictor for outcome in elderly ICU patients, and has been suggested to be used in various decision-making processes prior to and during an ICU admission. There are many instruments developed to assess frailty, but...

Cite
Flaatten H, Guidet B, Andersen FH, et al. Reliability of the Clinical Frailty Scale in very elderly ICU patients: a prospective European study. Ann Intensive Care. 2021;11(1):22doi: 10.1186/s13613-021-00815-7.
Flaatten, H., Guidet, B., Andersen, F. H., Artigas, A., Cecconi, M., Boumendil, A., Elhadi, M., Fjølner, J., Joannidis, M., Jung, C., Leaver, S., Marsh, B., Moreno, R., Oeyen, S., Nalapko, Y., Schefold, J. C., Szczeklik, W., Walther, S., Watson, X., Zafeiridis, T., de Lange, D. W. (2021). Reliability of the Clinical Frailty Scale in very elderly ICU patients: a prospective European study. Annals of intensive care, 11(1), 22. https://doi.org/10.1186/s13613-021-00815-7
Flaatten, Hans, et al. "Reliability of the Clinical Frailty Scale in very elderly ICU patients: a prospective European study." Annals of intensive care vol. 11,1 (2021): 22. doi: https://doi.org/10.1186/s13613-021-00815-7
Flaatten H, Guidet B, Andersen FH, Artigas A, Cecconi M, Boumendil A, Elhadi M, Fjølner J, Joannidis M, Jung C, Leaver S, Marsh B, Moreno R, Oeyen S, Nalapko Y, Schefold JC, Szczeklik W, Walther S, Watson X, Zafeiridis T, de Lange DW. Reliability of the Clinical Frailty Scale in very elderly ICU patients: a prospective European study. Ann Intensive Care. 2021 Feb 03;11(1):22. doi: 10.1186/s13613-021-00815-7. PMID: 33534010; PMCID: PMC7856616.
Copy Download .nbib Format: NLM
Effect of current density on the microstructure and morphology of the electrodeposited nickel coatings.

Turkish journal of chemistry

Boukhouiete A, Boumendjel S, Sobhi NE.
PMID: 34849070
Turk J Chem. 2021 Oct 19;45(5):1599-1608. doi: 10.3906/kim-2102-46. eCollection 2021.

The aim of this research work was to study the effect of deposition current density on microstructure and surface morphology of electrodeposited nickel coatings. For this purpose, nickel deposits have been synthesized by direct current from Watts bath without...

Cite
Boukhouiete A, Boumendjel S, Sobhi NE. Effect of current density on the microstructure and morphology of the electrodeposited nickel coatings. Turk J Chem. 2021;45(5):1599-1608doi: 10.3906/kim-2102-46.
Boukhouiete, A., Boumendjel, S., & Sobhi, N. E. (2021). Effect of current density on the microstructure and morphology of the electrodeposited nickel coatings. Turkish journal of chemistry, 45(5), 1599-1608. https://doi.org/10.3906/kim-2102-46
Boukhouiete, Amel, et al. "Effect of current density on the microstructure and morphology of the electrodeposited nickel coatings." Turkish journal of chemistry vol. 45,5 (2021): 1599-1608. doi: https://doi.org/10.3906/kim-2102-46
Boukhouiete A, Boumendjel S, Sobhi NE. Effect of current density on the microstructure and morphology of the electrodeposited nickel coatings. Turk J Chem. 2021 Oct 19;45(5):1599-1608. doi: 10.3906/kim-2102-46. eCollection 2021. PMID: 34849070; PMCID: PMC8596559.
Copy Download .nbib Format: NLM
Diversity-Oriented Synthesis: Amino Acetophenones as Building Blocks for the Synthesis of Natural Product Analogs.

Pharmaceuticals (Basel, Switzerland)

Eymery M, Tran-Nguyen VK, Boumendjel A.
PMID: 34832909
Pharmaceuticals (Basel). 2021 Nov 05;14(11). doi: 10.3390/ph14111127.

Diversity-Oriented Synthesis (DOS) represents a strategy to obtain molecule libraries with diverse structural features starting from one common compound in limited steps of synthesis. During the last two decades, DOS has become an unmissable strategy in organic synthesis and...

Cite
Eymery M, Tran-Nguyen VK, Boumendjel A. Diversity-Oriented Synthesis: Amino Acetophenones as Building Blocks for the Synthesis of Natural Product Analogs. Pharmaceuticals (Basel). 2021;14(11)doi: 10.3390/ph14111127.
Eymery, M., Tran-Nguyen, V. K., & Boumendjel, A. (2021). Diversity-Oriented Synthesis: Amino Acetophenones as Building Blocks for the Synthesis of Natural Product Analogs. Pharmaceuticals (Basel, Switzerland), 14(11), . https://doi.org/10.3390/ph14111127
Eymery, Mathias, et al. "Diversity-Oriented Synthesis: Amino Acetophenones as Building Blocks for the Synthesis of Natural Product Analogs." Pharmaceuticals (Basel, Switzerland) vol. 14,11 (2021). doi: https://doi.org/10.3390/ph14111127
Eymery M, Tran-Nguyen VK, Boumendjel A. Diversity-Oriented Synthesis: Amino Acetophenones as Building Blocks for the Synthesis of Natural Product Analogs. Pharmaceuticals (Basel). 2021 Nov 05;14(11). doi: 10.3390/ph14111127. PMID: 34832909; PMCID: PMC8619038.
Copy Download .nbib Format: NLM
Chemical composition, antioxidant activities, in an allergic asthma model, of .

Drug and chemical toxicology

Rouibah Z, Ben Mensour A, Rekik O, Boumendjel M, Taibi F, Bouaziz M, El Feki A, Messarah M, Boumendjel A.
PMID: 31645146
Drug Chem Toxicol. 2019 Oct 23;1-12. doi: 10.1080/01480545.2019.1679827. Epub 2019 Oct 23.

This study is an attempt to characterize the chemical composition and antioxidant activity of olive leaves variety (namely Bouricha variety) that is very widespread in the East of Algeria. The aqueous extract (AE) of leaves was initially analyzed for...

Cite
Rouibah Z, Ben Mensour A, Rekik O, et al. Chemical composition, antioxidant activities, in an allergic asthma model, of . Drug Chem Toxicol. 2019;1-12doi: 10.1080/01480545.2019.1679827.
Rouibah, Z., Ben Mensour, A., Rekik, O., Boumendjel, M., Taibi, F., Bouaziz, M., El Feki, A., Messarah, M., & Boumendjel, A. (2019). Chemical composition, antioxidant activities, in an allergic asthma model, of . Drug and chemical toxicology, 1-12. https://doi.org/10.1080/01480545.2019.1679827
Rouibah, Zineb, et al. "Chemical composition, antioxidant activities, in an allergic asthma model, of ." Drug and chemical toxicology vol. (2019): 1-12. doi: https://doi.org/10.1080/01480545.2019.1679827
Rouibah Z, Ben Mensour A, Rekik O, Boumendjel M, Taibi F, Bouaziz M, El Feki A, Messarah M, Boumendjel A. Chemical composition, antioxidant activities, in an allergic asthma model, of . Drug Chem Toxicol. 2019 Oct 23;1-12. doi: 10.1080/01480545.2019.1679827. Epub 2019 Oct 23. PMID: 31645146.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 21 entries